Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

NCT00090779 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

130

Enrollment

NETWORK

Sponsor class

Stopped The DSMB concluded that the findings regarding the primary analysis would persist and that no additional study goals would be achieved by continuing the study.

Conditions

HIV Infections

Interventions

DRUG: Emtricitabine/ tenofovir disoproxil fumarate
DRUG: Lopinavir/Ritonavir

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]
[object Object]